ISIN:SE0005676103

Ortoma Signs Agreement for Exclusive Distribution Rights in Japan

STOCKHOLM, Dec. 22, 2021 /PRNewswire/ -- Ortoma signs agreement with Johnson & Johnson K.K. for exclusive distribution rights inJapan of the Ortoma Treatment Solution for hip surgery. It is the first agreement that the company executes with a global strategic partner. The agreement allows for the...

2021-12-22 09:30 2432

World-class Performance with Assistance of Artificial Intelligence

STOCKHOLM, Dec. 12, 2019 /PRNewswire/ -- In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence. The system drastically reduces the time needed for pre-operatively planning of a hip implant in 3D, which has created a big interest for t...

2019-12-12 15:58 1261

Ortoma Initiates Expansion With Module for Spine Surgery

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery. -The conclusion after a number of perfor...

2019-11-08 21:40 6645

Ortoma Engages M&A Advisor

STOCKHOLM, May 2, 2019 /PRNewswire/ -- Ortoma and the Board of Directors have engaged MedWorld Advisors (www.medworldadvisors.com ) as M&A advisor to assist the company and the Board with management, evaluations, and negotiations in connection with any M&A transaction. During the past year, the ...

2019-05-02 15:32 5806

Ortoma Signs Exclusivity Agreement

STOCKHOLM, April 12, 2019 /PRNewswire/ -- Ortoma has signed an exclusivity agreement under a memorandum of understanding (MoU) with a European company that has Chinese ownership interests. With the MoU, Ortoma undertakes not to initiate discussions or negotiations with other companies with headqu...

2019-04-12 15:32 5718